← Evidence map

ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2024

Outcomes of Rituximab-abbs versus Rituximab in Patients with Diffuse Large B-Cell Lymphoma in a Noninferiority Study.

Helen W Wong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38935234